YBR126W-A is a protein of approximately 7.8 kDa, produced recombinantly in systems such as E. coli, yeast, or mammalian cells . The gene is annotated as "putative uncharacterized," indicating limited understanding of its biological function. Its association with yeast metabolism or structural processes is hypothesized but unconfirmed .
Hypothesis-Driven Studies: Used to investigate YBR126W-A’s localization, interaction partners, or role in yeast physiology .
Technical Assays: Suitable for Western blot, immunoprecipitation, or ELISA, pending empirical validation .
Uncharacterized Function: Lack of functional annotation limits mechanistic insights.
Antibody Specificity: No peer-reviewed studies confirm its binding specificity or cross-reactivity .
Commercial Availability: Sold as a research-grade reagent without clinical or diagnostic validation .
While YBR126W-A antibodies remain understudied, lessons from systematic antibody characterization initiatives like YCharOS highlight critical parameters for robust validation :
KEGG: sce:YBR126W-A
STRING: 4932.YBR126W-A
YBR126W-A refers to a specific open reading frame in the Saccharomyces cerevisiae genome. While the exact function of YBR126W-A remains under investigation, it likely shares functional similarities with other YBR family members involved in stress response mechanisms. Similar genes like YBR056W-A (MNC1) are expressed under stress conditions caused by toxic concentrations of heavy metal ions including manganese, cobalt, nickel, zinc, and copper . These genes belong to the CYSTM family, which plays roles in membrane-related functions and stress responses.
YBR126W-A may function similarly to YBR056W-A (MNC1) and YDR034W-B, which have been shown to be involved in overcoming manganese stress. Null mutants of these related genes demonstrate decreased cell concentration and lytic phenotypes when cultivated with excess manganese . The protein's exact cellular localization and molecular function require further investigation, as different YBR family proteins show varied subcellular distributions, with some predominantly in the plasma membrane and others in intracellular membranes.
Antibodies against yeast proteins such as YBR126W-A are typically generated through several methodological approaches:
Recombinant protein expression: The YBR126W-A gene is cloned into an expression vector, expressed in a suitable host system (often E. coli), purified using affinity chromatography, and used as an immunogen for antibody production.
Synthetic peptide approach: Unique peptide sequences from YBR126W-A are identified using bioinformatic analysis, synthesized, and conjugated to carrier proteins like keyhole limpet hemocyanin (KLH) before immunization.
Genetic immunization: DNA encoding the YBR126W-A protein can be used directly for immunization, allowing in vivo expression of the antigen and potentially better representation of native conformations.
For polyclonal antibodies, rabbits, goats, or chickens are commonly immunized with the antigen over several weeks. For monoclonal antibodies, a similar approach to that used for YFV antibodies can be employed, involving B cell isolation from immunized mice and fusion with myeloma cells to create stable hybridoma cell lines .
YBR126W-A antibodies serve multiple crucial research applications:
Protein expression analysis: Western blotting enables detection of YBR126W-A protein levels under different conditions, particularly stress conditions that may induce expression changes.
Protein localization studies: Immunofluorescence microscopy determines the subcellular localization of YBR126W-A, similar to how related proteins have been localized using GFP fusions. For example, Ydr034w-b-GFP was observed primarily in the plasma membrane and vacuolar membrane, while Ybr056w-a-GFP was detected in intracellular membranes .
Protein-protein interaction studies: Immunoprecipitation identifies proteins that interact with YBR126W-A under different conditions, helping to elucidate its functional networks.
Chromatin immunoprecipitation: If YBR126W-A has any role in transcriptional regulation or chromatin association, ChIP can map its genomic binding sites.
Flow cytometry: For quantitative analysis of YBR126W-A expression at the single-cell level, particularly useful for studying heterogeneous responses to stress.
Optimizing antibody specificity for low-abundance yeast proteins requires several technical approaches:
Epitope selection strategy: Use bioinformatic analysis to identify unique regions of YBR126W-A with minimal homology to other yeast proteins, especially closely related YBR family members. These regions should be prioritized as immunogens or for peptide antibody production.
Validation using genetic controls: Establish specificity by comparing antibody reactivity in wild-type versus YBR126W-A deletion strains. The absence of signal in knockout strains confirms antibody specificity, similar to validation approaches used for other yeast proteins.
Cross-adsorption techniques: Pre-adsorb antibodies with lysates from YBR126W-A deletion strains to remove antibodies recognizing other proteins, thereby enhancing specificity.
Signal amplification methods: For very low-abundance proteins, implement tyramide signal amplification or other enzymatic signal enhancement techniques to improve detection sensitivity while maintaining specificity.
Epitope tagging approaches: As an alternative strategy, use epitope-tagged versions of YBR126W-A (GFP, FLAG, HA, etc.) and corresponding well-characterized antibodies. This approach has been successfully implemented for related proteins like YBR056W-A and YDR034W-B using GFP fusions .
Based on methodologies used for related genes, the following approaches are recommended for studying YBR126W-A expression under stress conditions:
Fluorescent protein fusions: Generate YBR126W-A-GFP fusion constructs under native promoter control to monitor expression and localization in live cells, similar to the approach used for YBR056W-A and YDR034W-B .
Quantitative Western blotting: Use YBR126W-A-specific antibodies with appropriate loading controls (e.g., PGK1, TDH3) to quantify protein levels under various stresses.
Stress panel testing: Systematically test different stressors including:
Heavy metals (manganese, cobalt, nickel, zinc, copper, cadmium) at various concentrations
pH stress (alkaline and acidic conditions)
Oxidative stress (hydrogen peroxide)
Metabolic stressors (2,4-dinitrophenol as used in studies of related genes )
DNA-damaging agents (mitomycin C)
Membrane destabilizing agents (1,8-nonadiene)
Time-course experiments: Monitor changes in YBR126W-A expression over time after stress induction to characterize the dynamics of the response.
Subcellular localization changes: Track potential redistribution of YBR126W-A under different stress conditions, as proteins may relocalize as part of adaptive responses.
Post-translational modifications (PTMs) can significantly impact antibody recognition. To determine their effect on YBR126W-A antibody detection:
Phosphorylation analysis: Treat protein samples with phosphatase before Western blotting to determine if phosphorylation affects antibody binding. Compare band patterns and signal intensity before and after treatment.
Mass spectrometry mapping: Perform LC-MS/MS analysis to identify and map PTMs on immunoprecipitated YBR126W-A. This approach can utilize techniques like hydrogen-deuterium exchange mass spectrometry (HDX-MS) similar to those described for other proteins .
Site-directed mutagenesis: Generate mutants of potential PTM sites in YBR126W-A and compare antibody recognition between wild-type and mutant proteins to identify modification-sensitive epitopes.
2D gel electrophoresis: Separate different post-translationally modified forms of YBR126W-A based on charge and mass before Western blotting to visualize the diversity of modified forms.
PTM-specific antibodies: If specific modifications are identified and prove biologically significant, develop modification-specific antibodies that selectively recognize the modified forms of YBR126W-A.
For optimal immunofluorescence detection of YBR126W-A in yeast cells, consider the following protocol optimizations:
Fixation protocol optimization:
4% paraformaldehyde for 30-60 minutes preserves cell morphology while maintaining antigen accessibility
Methanol fixation for 6 minutes at -20°C may provide better accessibility for some antibodies
For difficult antigens, sequential fixation with formaldehyde followed by methanol can be effective
Cell wall digestion considerations:
Enzymatic spheroplasting with zymolyase (5-10 units/mL) or lyticase at 30°C
Monitor digestion by phase-contrast microscopy to ensure adequate spheroplasting while maintaining cellular integrity
Optimize digestion time (typically 15-30 minutes) as overdigestion causes cell lysis
Permeabilization options:
Blocking optimization:
3-5% BSA or 5-10% normal serum from the secondary antibody species
Include 0.1% Tween-20 to reduce background
For yeast cells, consider adding 1% non-fat dry milk to further reduce non-specific binding
Antibody incubation conditions:
Primary antibody dilutions ranging from 1:100 to 1:1000 (optimize empirically)
Overnight incubation at 4°C generally yields better results than shorter incubations
Include 0.1% Tween-20 in antibody dilution buffer to reduce background
For optimal extraction of YBR126W-A protein from yeast cells:
Mechanical disruption methods:
Glass bead lysis in appropriate buffer (vortex 8 × 30 seconds with 1-minute cooling intervals)
French press or high-pressure homogenization for larger sample volumes
Cryogenic grinding with liquid nitrogen for maximum protein preservation
Buffer composition optimization:
Standard extraction: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 10% glycerol
For membrane proteins: Consider 1% NP-40 or 0.5-1% digitonin instead of Triton X-100
Include 5 mM EDTA to chelate metals and inhibit metalloproteases
Essential protease inhibitors:
PMSF (1 mM, add fresh immediately before use)
Complete protease inhibitor cocktail (1×)
Pepstatin A (1 μg/mL) for aspartic proteases
Leupeptin (1 μg/mL) for serine and cysteine proteases
Phosphatase inhibitors (if studying phosphorylation):
Sodium orthovanadate (1 mM)
Sodium fluoride (10 mM)
β-glycerophosphate (10 mM)
Special considerations for stress-induced proteins:
For rigorous quantitative analysis of YBR126W-A expression in response to stressors:
Western blot quantification methodology:
Use fluorescent secondary antibodies rather than chemiluminescence for better quantitative linearity
Include internal loading controls (PGK1, TDH3) on the same blot
Employ image analysis software (ImageJ, LI-COR Image Studio) for densitometry
Create standard curves with recombinant protein for absolute quantification
Flow cytometry approach:
Experimental design considerations:
Include time-course measurements (15, 30, 60, 120, 240 minutes post-treatment)
Test dose-response relationships for each stressor
Include sufficient biological replicates (minimum n=3)
Normalize to untreated controls for each time point
Data presentation and statistical analysis:
Apply appropriate statistical tests (ANOVA with post-hoc tests for multiple comparisons)
Present fold-change data relative to untreated controls
Use heat maps for visualizing responses to multiple stressors simultaneously
| Stressor | Concentration | 30 min | 60 min | 120 min | 240 min |
|---|---|---|---|---|---|
| Control | - | 1.0 | 1.0 | 1.0 | 1.0 |
| Mn²⁺ | 1 mM | 2.1 | 3.5 | 4.2 | 3.8 |
| Mn²⁺ | 5 mM | 3.6 | 5.2 | 6.1 | 5.7 |
| Co²⁺ | 1 mM | 1.4 | 2.3 | 3.1 | 2.8 |
| Ni²⁺ | 1 mM | 1.8 | 2.7 | 3.5 | 3.2 |
| Zn²⁺ | 1 mM | 2.3 | 3.2 | 3.9 | 3.6 |
| Cu²⁺ | 1 mM | 2.5 | 3.8 | 4.5 | 4.1 |
| Cd²⁺ | 1 mM | 1.2 | 1.9 | 2.4 | 2.2 |
Table 1: Example data format for presenting YBR126W-A expression changes in response to metal stressors. Values represent fold change in protein levels relative to untreated control. Data are means of three biological replicates.
Non-specific bands in Western blots with YBR126W-A antibody could be attributed to several technical factors:
Cross-reactivity with related proteins:
YBR126W-A likely shares sequence homology with other yeast proteins, especially other YBR family members
Solution: Pre-adsorb antibody with lysates from YBR126W-A deletion strains
Validation approach: Compare patterns in wild-type versus YBR126W-A deletion strains
Protein degradation issues:
YBR126W-A may be sensitive to proteolysis during extraction, generating fragment bands
Solution: Use fresh samples, maintain cold temperatures throughout processing
Optimization: Increase protease inhibitor concentrations and variety
Testing approach: Compare fresh samples versus those subjected to intentional degradation
Post-translational modifications:
Different bands might represent modified forms of YBR126W-A
Investigation method: Treat samples with phosphatases or glycosidases and observe band pattern changes
Analysis approach: Use 2D gel electrophoresis to separate modified forms
Antibody optimization parameters:
Adjust blocking conditions (test 5% milk, 3% BSA, or commercial blockers)
Optimize primary antibody concentration with dilution series (1:500 to 1:5000)
Increase washing stringency (add 0.1-0.3% SDS to TBST wash buffer)
Test different membrane types (PVDF vs. nitrocellulose)
Sample preparation considerations:
Ensure complete denaturation (boil samples adequately in SDS sample buffer)
Filter lysates to remove insoluble material
Use freshly prepared reagents, particularly reducing agents
To effectively distinguish between YBR126W-A and closely related yeast proteins:
Antibody design and validation strategies:
Generate antibodies against unique regions with minimal sequence homology to related proteins
Use peptide arrays to map and identify highly specific epitopes
Validate specificity with YBR126W-A deletion strains as negative controls
Test for cross-reactivity with purified related proteins
Alternative tagging approaches:
Create strains with epitope-tagged versions of YBR126W-A (HA, FLAG, MYC)
Use well-characterized commercial antibodies against these tags
Create double-tagged strains to compare localization patterns with related proteins
Expression pattern analysis:
Mass spectrometry validation:
Confirm the identity of immunoprecipitated or Western blot bands by mass spectrometry
Use targeted MS approaches like selected reaction monitoring (SRM) for specific peptides unique to YBR126W-A
Analyze post-translational modification patterns that may differ between related proteins
Functional genomics approach:
Compare phenotypes of deletion strains for YBR126W-A versus related genes
Use synthetic genetic arrays to identify unique genetic interactions
Create reporter constructs driven by the YBR126W-A promoter to characterize expression patterns
Based on the role of related genes in metal stress response :
Metal exposure experimental design:
Systematically test YBR126W-A expression after exposure to different metals (Mn²⁺, Co²⁺, Ni²⁺, Zn²⁺, Cu²⁺, Cd²⁺)
Perform dose-response (0.1-10 mM) and time-course analyses (15 min to 24 h)
Compare response patterns to known metal response genes
Use the experimental approach demonstrated for YBR056W-A and YDR034W-B
Functional studies with deletion strains:
Create YBR126W-A deletion strains and test metal sensitivity/resistance
Measure growth rates in liquid culture with various metal concentrations
Conduct spot assays on solid media containing different metals
Compare phenotypes with those observed for YBR056W-A and YDR034W-B null mutants, which showed decreased cell concentration and lytic phenotype with excess manganese
Subcellular localization studies:
Metal content analysis:
Use inductively coupled plasma mass spectrometry (ICP-MS) to measure cellular metal content
Compare wild-type and YBR126W-A deletion strains
Analyze subcellular fractions to determine compartmentalization
Genetic interaction studies:
Test for synthetic interactions between YBR126W-A and known metal homeostasis genes
Perform epistasis analysis with related genes like YBR056W-A (MNC1)
Create double and triple mutants to identify redundant functions
| Metal | Growth (WT) | Growth (Δybr126w-a) | YBR126W-A Expression | Phenotype |
|---|---|---|---|---|
| Mn²⁺ | Normal | Reduced | Strongly induced | Cell lysis |
| Co²⁺ | Normal | Slightly reduced | Moderately induced | Vacuole fragmentation |
| Ni²⁺ | Normal | Reduced | Strongly induced | Cell wall defects |
| Zn²⁺ | Normal | Normal | Mildly induced | No visible phenotype |
| Cu²⁺ | Normal | Severely reduced | Strongly induced | Severe growth arrest |
Table 2: Hypothetical data showing the relationship between metal exposure, YBR126W-A expression, and phenotypic consequences in wild-type and deletion strains.
If YBR126W-A is suspected to interact with DNA directly or as part of a complex:
ChIP protocol optimization for yeast cells:
Crosslinking: Use 1% formaldehyde for 15 minutes at room temperature
Cell lysis: Perform enzymatic spheroplasting with zymolyase followed by detergent lysis
Chromatin fragmentation: Sonicate to achieve 200-500 bp fragments (verify by gel electrophoresis)
Immunoprecipitation: Incubate fragmented chromatin with YBR126W-A antibody overnight at 4°C
Washing: Implement increasing stringency washes to minimize background
Critical controls for ChIP experiments:
Input control: Process an aliquot of sonicated chromatin before immunoprecipitation
Negative control: Perform parallel IP with non-specific IgG
Positive control: Include IP for a well-characterized DNA-binding protein
Genetic control: Use YBR126W-A deletion strain as specificity control
Technical alternative: Use epitope-tagged YBR126W-A with tag-specific antibodies
Analysis methods and data interpretation:
ChIP-qPCR: Design primers for suspected binding regions and control regions
ChIP-seq: For genome-wide binding profile analysis
Peak calling: Use MACS2 or similar algorithms optimized for yeast genomes
Motif analysis: Employ MEME or similar tools to identify binding motifs
Data integration: Combine with transcriptomic data to connect binding with function
Functional validation approaches:
Mutagenesis of identified binding sites
Reporter assays with wild-type and mutated binding sites
Genetic interaction studies with transcription factors or chromatin modifiers
In vitro DNA binding assays with purified protein
For comprehensive characterization of YBR126W-A interactome using mass spectrometry:
Sample preparation optimization:
Affinity purification: Use YBR126W-A antibodies or epitope-tagged YBR126W-A
Crosslinking approaches: Consider DSP or formaldehyde crosslinking to capture transient interactions
Negative controls: Include IgG pulldowns and/or bait purification from deletion strains
Condition variation: Compare interactomes under normal and stress conditions
Mass spectrometry workflow:
Sample processing: In-gel or in-solution digestion with trypsin
LC-MS/MS analysis: Use high-resolution instruments (Q-Exactive, Orbitrap)
Data acquisition: Implement data-dependent acquisition for discovery
Parallel reaction monitoring (PRM) for targeted validation of specific interactions
Data analysis framework:
Search engines: Use MaxQuant or Proteome Discoverer for peptide/protein identification
Interaction scoring: Implement SAINT or similar algorithms to score interaction confidence
Quantification: Use label-free quantification or SILAC for comparative interactomics
Visualization: Generate interaction networks using Cytoscape or similar tools
Interaction validation strategies:
Reciprocal pulldowns: Verify key interactions by pulling down with antibodies against partners
Co-localization studies: Use fluorescence microscopy to confirm spatial proximity
Functional studies: Test phenotypic consequences of disrupting specific interactions
Structural studies: For key interactions, consider hydrogen-deuterium exchange mass spectrometry (HDX-MS) similar to approaches used for other proteins
Data presentation example:
| Interaction Partner | Spectral Count Ratio (Bait/Control) | Confidence Score | Interaction Enhanced by Stress |
|---|---|---|---|
| Protein A | 24.5 | 0.98 | Yes (Mn²⁺) |
| Protein B | 18.3 | 0.97 | No |
| Protein C | 12.7 | 0.89 | Yes (oxidative) |
| Protein D | 8.4 | 0.76 | No |
| Protein E | 6.2 | 0.68 | Yes (Cd²⁺) |
Table 3: Example interactome data showing putative YBR126W-A interaction partners identified by affinity purification-mass spectrometry.
YBR126W-A antibodies can be powerful tools in systems biology approaches through:
Multi-omics integration strategy:
Use antibodies for proteomics (immunoprecipitation-mass spectrometry)
Combine with transcriptomics data from RNA-seq
Integrate with metabolomics to link YBR126W-A function to metabolic changes
Correlate with phenotypic data from deletion strains
Network analysis methodology:
Construct protein-protein interaction networks centered on YBR126W-A
Develop co-expression networks similar to those described for YDL012C, YDR210W, and YBR016W
Identify functional modules and pathways enriched for YBR126W-A interactions
Map genetic interactions through synthetic genetic array analysis
Temporal dynamics investigation:
Track time-resolved changes in YBR126W-A expression, localization, and interactions
Determine the order of events in stress response pathways
Identify feedback loops and regulatory mechanisms
Model dynamic responses using computational approaches
Cross-species comparative analysis:
Compare YBR126W-A function with orthologs in other fungi
Identify conserved and divergent aspects of metal stress responses
Use evolutionary conservation to predict functional domains
Pathway mapping and modeling:
Position YBR126W-A within known stress response pathways
Generate predictive models of cellular behavior under stress
Test model predictions through targeted experiments
Refine models iteratively based on experimental results
To investigate structural aspects of YBR126W-A function:
Epitope mapping strategy:
Conformation-specific antibody development:
Generate antibodies that recognize specific structural states
Use these to track conformational changes under different conditions
Employ hydrogen-deuterium exchange mass spectrometry (HDX-MS) to validate conformational changes
Structure-function studies:
Use site-directed mutagenesis to modify predicted functional domains
Test mutants with antibodies to ensure proper expression
Correlate structural changes with functional outcomes
Develop domain-specific antibodies to track individual regions
Protein interaction mapping:
Use antibody-based pull-downs combined with deletion constructs
Map interaction domains and critical residues
Correlate with computational predictions of structural features
Perform competition assays to identify interaction surfaces
In situ structural analysis:
Use proximity labeling approaches with domain-specific antibodies
Map neighborhood relationships within the cell
Track structural rearrangements during stress responses